Iovance Biotherapeutics
Price & Volume
Stats
See more52W Range | $5.05-$18.33 |
Market Cap | $1.7B |
Shares Short | 63M |
Financials
See moreRevenue (12 Mos) | $90.8M |
Revenue Growth (YoY) | 12,385.1% |
Gross Profit (12 Mos) | $8M |
Diluted EPS | -$1.48 |
News
See moreYahoo Finance • 23 hours ago
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance • 4 days ago
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
Yahoo Finance • 12 days ago
Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
Yahoo Finance • 26 days ago
Meet the Growth Stock That Could Soar 280%, According to Wall Street Analysts
About
CEO | Dr. Frederick G. Vogt Esq., J.D., Ph.D. |
CFO | Mr. Jean-Marc Bellemin M.B.A. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 557 |
